U.S. District Judge Colleen McMahon wrote in her decision that she cannot approve the settlement — part of Purdue Pharma’s restructuring plan that was approved by a bankruptcy judge in September — because it frees the Sackler family, the drugmakers’ founders and owners, from liability in future opioid-related cases.
The Sackler family made immunization from opioid claims a requirement in exchange for paying $4.5 from their personal wealth to the bankruptcy settlement, but Ms. McMahon said the bankruptcy code does not allow a judge to grant such immunity.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
